Effect of piperlongumine on drug resistance reversal in human retinoblastoma HXO-RB44/VCR and SO-Rb50/CBP cell lines

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 3, 2015, Pages 2525-2534

  Wang, Xiao Qiang ^a   Wang, Yu Chuan ^a   Guo, Ya Tu ^a   Tang, Xin ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Piperlongumine human; Resistance; Retinoblastoma drug

Indexed keywords

1,3 DIOXOLANE DERIVATIVE; PIPERLONGUMININE;

APOPTOSIS; DRUG EFFECTS; DRUG RESISTANCE; FLOW CYTOMETRY; HUMAN; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; RETINA TUMOR; RETINOBLASTOMA; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; DIOXOLANES; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION; RETINAL NEOPLASMS; RETINOBLASTOMA; SIGNAL TRANSDUCTION;

EID: 84933034341     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. De Jong MC, Kors WA, de Graaf P, Castelijns JA, Kivelä T and Moll AC. Trilateral retinoblastoma: a systematic review and meta-analysis. Lancet Oncol 2014; 10: 1157-67.
2. Shields CL, Lally SE, Leahey AM, Jabbour PM, Caywood EH, Schwendeman R and Shields JA. Targeted retinoblastoma management: when to use intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Curr Opin Ophthalmol 2014; 25: 374-85.
3. Raj L, Ide T, Gurkar AU, Foley M, Schenone M, Li X, Tolliday NJ, Golub TR, Carr SA, Shamji AF, Stern AM, Mandinova A, Schreiber SL and Lee SW. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 2011; 475: 231-4
4. Roh JL, Kim EH, Park JY, Kim JW, Kwon M and Lee BH. Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer. Oncotarget 2014; 19: 9227-38.
5. Liu QR, Liu JM, Chen Y, Xie XQ, Xiong XX, Qiu XY, Pan F, Liu D, Yu SB and Chen XQ. Piperlongumine inhibits migration of glioblastoma cells via activation of ROS-dependent p38 and JNK signaling pathways.Oxid Med Cell Longev 2014; 2014: 653732.
6. Jarvius M, Fryknäs M, D'Arcy P, Sun C, Rickardson L, Gullbo J, Haglund C, Nygren P, Linder S and Larsson R. Piperlongumine induces inhibition of the ubiquitin-proteasome system in cancer cells. Biochem Biophys Res Commun 2013; 2: 117-23.
7. Furniss KL, Tsai HJ, Byl JA, Lane AB, Vas AC, Hsu WS, Osheroff N and Clarke DJ. Direct monitoring of the strand passage reaction of DNA topoisomerase II triggers checkpoint activation. PLoS Genet 2013; 10: e1003832.
8. Zhu Y, Liu XJ, Yang P, Zhao M, Lv LX, Zhang GD, Wang Q and Zhang L. Alkylglyceronephosphate synthase (AGPS) alters lipid signaling pathways and supports chemotherapy resistance of glioma and hepatic carcinoma cell lines. Asian Pac J Cancer Prev 2014; 7: 3219-26.
9. Zhu Y, Zhang L, Zhang GD, Wang HO, Liu MY, Jiang Y, Qi LS, Li Q and Yang P. Potential Mechanisms of Benzyl Isothiocyanate Sup-pression of Invasion and Angiogenesis by the U87MG Human Glioma Cell Line. Asian Pac J Cancer Prev 2014; 19: 8225-8.
10. Busser B, Sancey L, Josserand V, Niang C, Khochbin S, Favrot MC, Coll JL and Hurbin A. Amphiregulin promotes resistance to gefitinib in nonsmall cell lung cancer cells by regulating Ku70 acetylation. Mol Ther 2010; 18: 536-543.
11. Hu CT, Cheng CC, Pan SM, Wu JR and Wu WS. PKC mediates fluctuant ERK-paxillin signaling for hepatocyte growth factor-induced migration of hepatoma cell HepG2. Cell Signal 2013; 25: 1457-67.
12. Collu F and Cascella M. Multidrug resistance and efflux pumps: insights from molecular dynamics simulations. Curr Top Med Chem 2013; 13: 3165-83.
13. Zinzi L, Contino M, Cantore M, Capparelli E, Leopoldo M and Colabufo NA. ABC transporters in CSCs membranes as a novel target for treating tumor relapse. Front Pharmacol 2014; 5: 163.
14. Tamási V, Monostory K, Prough RA and Falus A. Role of xenobiotic metabolism in cancer: involvement of transcriptional and miRNA regulation of P450s. Cell Mol Life Sci 2011; 68: 1131-46.
15. Mao ZP, Zhao LJ, Zhou SH, Liu MQ, Tan WF and Yao HT. Expression and significance of glucose transporter-1, P-glycoprotein, multidrug resistance-associated protein and glutathione S-transferase-Π in laryngeal carcinoma. Oncol Lett 2015; 9: 806-810.
16. Groner B, Weiss A. Targeting survivin in cancer: novel drug development approaches. BioDrugs 2014; 28: 27-39
17. Xiao H and Liu M. Atypical protein kinase C in cell motility. Cell Mol Life Sci 2013; 70: 3057-66.
18. Fogh BS, Multhaupt HA and Couchman JR. Protein kinase C, focal adhesions and the regulation of cell migration. J Histochem Cytochem 2014; 62: 172-84.